Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Triple Negative Breast Cancer
Interventions: DRUG: Durvalumab|RADIATION: Radiation Therapy|DRUG: Carboplatin|DRUG: Paclitaxel
Sponsor: Cedars-Sinai Medical Center
Collaborators: AstraZeneca